(Bromomethyl)cyclobutane

GMP Propyl Gallate

THERAPEUTICAL USE: Anti-Ulcer, Gastro-Intestinal, Disorder TreatmentREGULATORY DOCUMENTATION: CEP / US DMF

THERAPEUTICAL USE: Anti-Ulcer  Gastro-Intestinal  Disorder Treatment REGULATORY DOCUMENTATION: CEP

THERAPEUTICAL USE: Anti-Inflammatory, Anti-Allergic, Anti-AsthmaticREGULATORY DOCUMENTATION: CEP / US DMF

Therapeutical use : Treatment of HIV Infection Currently in development 

Therapeutical use : Management of asthma and COPD Currently in development

Minakem SAS provides a wide range of products which includes (bromomethyl) cyclopropane. It belongs to cycloalkanes category. Contact us for more information.

Minakem SAS provides a wide range of products which includes bromocyclobutane. It belongs to cycloalkanes. Contact us for more information.

Minakem SAS provides a wide range of products which includes (1R,2R)-1,2-diaminocyclohexane. It belongs to cycloalkanes. Contact us for more information.

Minakem SAS provides a wide range of products which includes (1R)-(10-camphorsulfonyl)imine. It belongs to miscellaneous. Contact us for more information.

Minakem SAS provides a wide range of products which includes (1R)-(10-camphorsulfonyl)oxaziridine. It belongs to miscellaneous. Contact us for more information.

Minakem SAS provides a wide range of products which includes (2-fluoro-3-methoxyphenyl)boronic acid. It belongs ot benzene derivatives, boronic acids category. Contact us for more information.

GENERICS SMALL MOLECULES
CORTICO STEROIDS
HPAPI & APIs

Minakem is a global supplier of generic APIs to the Pharma and Biotech industries. Minakem has regulatory expertise in supporting customers for their filings in most countries. - View our product catalog

Minakem is a fully integrated and trusted development partner and commercial manufacturer for pharmaceutical companies. Beyond Minakem's recognized expertise in process development, scale-up, commercial cGMP production and HPAPI capability, we offer the full range of services from route scouting to regulatory dossier approvals.